Complete Radiopharmaceutical Therapy Solutions

Learn More

Complete Clinical Imaging Core Lab Capabilities

Learn More

Unmatched PSMA-PET Solutions: Advancing the Standard of Care

Learn More

Learn What Invicro's IQ Analytics Platform Can Do

Learn More

Gain New Insights in Early Drug Discovery

Learn More

SNMMI Annual Meeting 2024

Stop by booth #1822 to discover how our comprehensive molecular imaging solutions and expert team can elevate your research endeavors. At Invicro, we specialize in providing cutting-edge scientific and operational expertise tailored to meet the unique needs of preclinical and clinical projects across various therapeutic areas and modalities. Explore our capabilities in radiochemistry, PET, and SPECT imaging, which enable precise biologics biodistribution imaging and radioligand therapy. With our expertise in dosimetry solutions our team can simplify and provide insights into the complex services related to dosimetry for radiopharmaceutical development analysis.

Let’s Chat

Pioneering BLI Research for 20+ Years

Premier Bioluminescence Imaging Services

Invicro has made a profound impact in the field of bioluminescence imaging (BLI) research for our pharma partners with our leadership being the first to bring this disrupting technology into the CRO space. The speed & precision of our image analytics and reporting, coupled with highly performing deep tissue tumor models has allowed us to stay at the forefront of this imaging modality.

Contact us to discuss BLI driven PK/PD or efficacy studies.

Let’s Chat

SUPPORTING
ALL DRUG
DISCOVERY &
DEVELOPMENT
PHASES

DRUG
DISCOVERY
EARLY
CLINICAL
LATE
PHASE
  • 3,500+ Research Trials Managed
  • 535+ Clinical Trials Managed
  • 40,000,000+ (DICOM) Images Processed
  • 800+ Molecules Labeled

CNS Webinar Series

Discover our capabilities from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials.

Watch Now

Oncology Webinar Series

Gain insights on ground-breaking techniques and imaging methods in preclinical through late-phase oncology studies.

Watch Now